A Phase I study of ‘Tomudex’ and gemcitabine in advanced cancer
C. Cripps(Canadian Partnership Against Cancer), A. Abugaber, David W. Fry, Gerald Batist(Jewish General Hospital), R Kolendowicz, Simone Dahrouge(Ottawa Regional Cancer Foundation), Andrew McQuillan(Hollywood Orthopaedic Group)
Cited by 2
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy
|Journal of Clinical Oncology|2016|291
Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144
|Journal of Clinical Oncology|2006|167